White House Suggests Medicare Rebate Mandates Similar to Those of Medicaid

May 15, FiercePharma reported “White House budget director suggests rebate mandates for Medicare to cut drug prices.” The story states in part that “The industry’s response was immediate and definitive in its opposition. “Any type of government price-setting in Medicare Part D would limit access to needed medicines and increase costs for beneficiaries,” PhRMA spokeswoman Holly Campbell told the newspaper. “It also would destabilize a successful, market-based program in which beneficiaries are highly satisfied and would curtail investment in research and development needed to discover new treatments. The risks of these proposals clearly outweigh the benefits.” Click here to read the full story or here to contact us for help with your drug or medical device development program.